ArticleCancer discovery2022

PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.

Amish J Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.